FDA approves 1st treatment for high-risk smoldering myeloma
The U.S. Food and Drug Administration (FDA) has approved Darzalex Faspro (daratumumab and hyaluronidase) for adults with high-risk smoldering multiple myeloma, making it…
The U.S. Food and Drug Administration (FDA) has approved Darzalex Faspro (daratumumab and hyaluronidase) for adults with high-risk smoldering multiple myeloma, making it…
Women often play the role of caregiver. When our loved ones are sick or hurting, we’re the ones ladling out chicken soup, whether it’s for…
It happened at the drugstore. My shoulders were tight as I leaned against the counter. It was the fourth time that evening that I was…
One-time use of CB-011, Caribou Biosciences’ off-the-shelf CAR T-cell therapy candidate, showed a manageable safety profile and resulted in lasting responses in adults with…
I see a lot of jargon in my line of work. A big part of my job is helping reporters translate it into something our…
As a caregiver to my mum, who has myeloma, I usually experience some moments of quietness. One of these moments might be when we’re…
The U.S. Food and Drug Administration (FDA) has granted fast track designation to HDP-101 (pamlectabart tismanitin), a multiple myeloma therapy currently in early clinical…
I am a longtime journalist with a firm belief that knowledge is power. My life’s work has been to answer the who, what, where, when,…
The U.S. Food and Drug Administration (FDA) has approved GSK‘s Blenrep (belantamab mafodotin) for adults with relapsed or refractory multiple myeloma. The approval…
“Let me know if you need anything.” No matter how well-intentioned that statement sounds, I personally believe it’s the most useless thing someone can say…